Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-02 Sale |
2024-01-03 4:56 pm |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
3,000,000 | $11.05 | $33,150,000 | 51,929,426 (Direct) |
View |
| 2023-10-02 Sale |
2023-10-04 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer |
1,200,000 | $10.43 | $12,520,990 | 39,377,224 (Direct) |
View |
| 2023-10-02 Purchase |
2023-10-04 5:15 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner |
1,526,316 | $38 | $58,000,008 | 79,805,331 (Direct) |
View |
| 2023-09-28 Sale |
2023-10-02 9:05 pm |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
6,896,144 | $11.55 | $79,650,463 | 5,023,787 (Indirect) |
View |
| 2023-09-28 Sale |
2023-10-02 9:00 pm |
Roivant Sciences Ltd. | ROIV | SVF Investments (UK) Ltd SVF Holdings (UK) LLP SoftBank Vision Fund L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner |
10,000,000 | $12.6 | $126,000,000 | 73,031,667 (Indirect) |
View |
| 2023-09-28 Sale |
2023-10-02 8:55 pm |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
10,000,000 | $11.55 | $115,500,000 | 5,023,787 (Indirect) |
View |
| 2023-09-28 Sale |
2023-10-02 8:43 pm |
Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director 10% Owner |
10,000,000 | $11.55 | $115,500,000 | 5,023,787 (Indirect) |
View |
| 2023-09-27 Sale |
2023-09-29 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
500,000 | $13.02 | $6,510,000 | 14,418,581 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-19 Option Award |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
3,366 | $0 | 78,342 (Direct) |
View |
| 2024-01-20 Tax Withholding |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $10.35 | 1,011,953 (Direct) |
View |
| 2024-01-20 Tax Withholding |
2024-01-23 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
12,377 | $10.35 | 532,207 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
611,393 | $6.4 | 73,633,116 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
251,538 | $11.5 | 73,633,116 (Direct) |
View |
| 2023-12-27 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
133,911 | $11.58 | 73,633,116 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
275,227 | $0 | 73,633,116 (Direct) |
View |
| 2023-12-28 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,913 | $11.37 | 273,079 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
85,232 | $6.4 | 4,195,421 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
47,351 | $11.5 | 4,195,421 (Direct) |
View |
| 2023-12-27 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
22,043 | $11.58 | 4,195,421 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
38,453 | $0 | 4,195,421 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
159,100 | $6.4 | 8,109,865 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
28,411 | $11.5 | 8,109,865 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
71,365 | $0 | 8,109,865 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,894 | $11.5 | 279,415 (Direct) |
View |
| 2023-12-27 Tax Withholding |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
6 | $11.58 | 279,415 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 9:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
13 | $0 | 279,415 (Direct) |
View |
| 2023-12-20 Tax Withholding |
2023-12-22 7:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,003 | $9.96 | 544,584 (Direct) |
View |
| 2023-12-20 Tax Withholding |
2023-12-22 7:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,945 | $9.96 | 1,006,488 (Direct) |
View |
| 2023-12-20 Tax Withholding |
2023-12-22 7:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,364 | $9.96 | 192,282 (Direct) |
View |
| 2023-11-29 Other |
2023-12-01 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,360 | $9.13 | 277,282 (Direct) |
View |
| 2023-11-22 Other |
2023-11-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,549 | $8.68 | 577,136 (Direct) |
View |
| 2023-11-22 Other |
2023-11-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,415 | $8.68 | 195,061 (Direct) |
View |
| 2023-11-22 Other |
2023-11-27 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,318 | $8.68 | 1,028,751 (Direct) |
View |
| 2023-10-30 Other |
2023-11-01 9:39 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,360 | $8.39 | 279,712 (Direct) |
View |
| 2023-10-24 Other |
2023-10-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
18,261 | $8.99 | 595,397 (Direct) |
View |
| 2023-10-24 Other |
2023-10-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
12,489 | $8.99 | 1,041,240 (Direct) |
View |
| 2023-10-24 Other |
2023-10-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,563 | $8.99 | 196,624 (Direct) |
View |
| 2023-10-17 Other |
2023-10-18 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
687 | $10.3 | 75,456 (Direct) |
View |
| 2022-10-16 Option Award |
2023-10-18 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
1,594 | $0 | 75,456 (Direct) |
View |
| 2023-10-16 Option Award |
2023-10-18 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
2,269 | $0 | 74,976 (Direct) |
View |
| 2023-10-16 Option Award |
2023-10-18 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
1,226 | $0 | 20,331 (Direct) |
View |
| 2023-10-16 Option Award |
2023-10-18 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director |
1,269 | $0 | 11,358 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer |
1,200,000 | $3.85 | 39,377,224 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 9:30 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer |
1,200,000 | $0 | 39,377,224 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-04 5:15 pm |
N/A N/A |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner |
4,473,684 | $38 | 79,805,331 (Direct) |
View |
| 2023-09-29 Other |
2023-10-03 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
2,483 | $11.86 | 282,195 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
500,000 | $3.85 | 14,418,581 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
500,000 | $0 | 14,418,581 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
53,033 | $6.4 | 8,226,011 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
28,411 | $11.5 | 8,226,011 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer |
27,790 | $0 | 8,226,011 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
28,411 | $6.4 | 4,441,820 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
47,351 | $11.5 | 4,441,820 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
17,762 | $0 | 4,441,820 (Direct) |
View |
| 2023-09-28 Other |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
10,243 | $12.67 | 4,441,820 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
203,798 | $6.4 | 74,416,678 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
251,539 | $11.5 | 74,416,678 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
119,534 | $0 | 74,416,678 (Direct) |
View |
| 2023-09-28 Other |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner |
61,947 | $12.67 | 74,416,678 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A 2026-03-31 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,894 | $11.5 | 276,736 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
169 | $0 | 276,736 (Direct) |
View |
| 2023-09-28 Other |
2023-09-29 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
92 | $12.67 | 276,736 (Direct) |
View |
| 2023-09-22 Other |
2023-09-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,416 | $10.19 | 611,813 (Direct) |
View |
| 2023-09-22 Other |
2023-09-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,403 | $10.19 | 197,950 (Direct) |
View |
| 2023-09-22 Other |
2023-09-26 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
11,227 | $10.19 | 1,044,948 (Direct) |
View |
| 2023-09-18 Other |
2023-09-20 9:33 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
6,752 | $11.17 | 80,614 (Direct) |
View |